Vaccine Social Media Randomized Intervention Trial (VSMRCT)
This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns.
The study has two hypothesis:
- Parents receiving usual care plus social media website will demonstrate higher early childhood immunization rates to parents receiving either usual plus non interactive website or usual care only.
- Parents receiving usual care plus social media website will demonstrate positive changes in knowledge, attitudes and beliefs supporting vaccination compared to parents receiving either usual care plus non-interactive website or usual care only.
|Communicable Diseases||Behavioral: Social Media plus information pages Behavioral: Vaccine Information Pages|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
|Official Title:||Randomized Intervention Trial to Evaluate a Vaccine Social Media Website|
- Days under-immunized [ Time Frame: 2 years ]Days under-immunized is a metric to identify immunization delay. For each vaccine dose calculate the difference between when the vaccine dose was actually administered and when the vaccine dose should have been administered according to the Advisory Committee on Immunization Practices (ACIP) schedule. That difference is summed across all doses and vaccines for a total number of days under-immunized for each child. Total days under immunized was calculated 200 days after life or after enrollment. If someone had 0 days at that time they were considered "up to date".
- Knowledge, Attitudes and Beliefs about immunizations [ Time Frame: Baseline, Child age 4-6 months, Child age 11-13 months ]Knowledge, attitudes, and beliefs will be measured with a survey at up to 3 time points during the study: 1) Initial enrollment in the study, 2) child's ag=4-6 months and 3) child's age=11-13 months.
|Study Start Date:||August 2013|
|Study Completion Date:||November 2016|
|Primary Completion Date:||November 2016 (Final data collection date for primary outcome measure)|
Experimental: Social media plus information pages
Participants will have access to the vaccine social media website with information pages and social media features including discussion forums, blogs, chat with an expert, and ask an expert.
Behavioral: Social Media plus information pages
Participants will receive access to the study vaccine website information pages and social media feature including blogs, discussion forums, expert chats, and ask an expert.
Experimental: Information Pages
Participants will have website access to vaccine information pages.
Behavioral: Vaccine Information Pages
Participants will receive access to the study vaccine website information pages.
No Intervention: Usual Care
Participants will not have access to the vaccine website. They will receive pediatric care as usual.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01873040
|United States, Colorado|
|Kaiser Permanente Colorado Institute for Health Research|
|Denver, Colorado, United States, 80231|
|Principal Investigator:||Jason M Glanz, PhD||Kaiser Permanente|